Prostate pill hopes
THOUSANDS of men have been given hope with a pill that could keep prostate cancer at bay.
The daily dose appears to shrink tumours or stop them growing in the late stages of the disease.
Scientists at Memorial Sloan-Kettering Cancer Centre in New York tested the MDV3100 drug on 30 men, 40 per cent of whose levels of cancer-indicating chemicals were more than halved.
The study is published in the journal science.
The drug could be on the market in three years.
Prostate cancer kills 10,000 men a year in Britain.
EXPRESS RETIREMENT: THE LATEST NEWS AND ADVICE FOR SILVER SURFERS